| 1 |
Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ. Selected major risk factors and global and regional burden of disease. Lancet 2002;360:1347-1360.
DOI
ScienceOn
|
| 2 |
Cherry DK, Woodwell DA. National Ambulatory Medical Care Survey: 2000 summary. Adv Data 2002;328:1-32.
|
| 3 |
World Health Organization. Preventing chronic disease: a vital investment. Geneva, World Health Organization, 2005.
|
| 4 |
Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ 2003;326:1419.
DOI
ScienceOn
|
| 5 |
Jee SH, Suh I, Kim IS, Appel LJ. Smoking and atherosclerotic cardiovascular disease in men with low levels of serum cholesterol: the Korea medical insurance corporation study. JAMA 1999;282:219-2155.
DOI
ScienceOn
|
| 6 |
Borzecki AM, Oliveria SA, Berlowitz DR. Barriers to hypertension control. Am Heart J 2005;149:785-794.
DOI
ScienceOn
|
| 7 |
Wagner EH. Chronic disease management: what will it take to improve care for chronic illness? Eff Clin Pract 1998;1:2-4.
|
| 8 |
Steinman MA, Fischer MA, Shlipak MG, et al. Clinician awareness of adherence to hypertension guidelines. Am J Med 2004;117:747-754.
DOI
ScienceOn
|
| 9 |
Kim SY, Cho IS, Lee JH, et al. Physician factors associated with the blood pressure control among hypertensive Patients. J Prev Med Public Health 2007;40:487-494.
DOI
ScienceOn
|
| 10 |
Kim KI, Kim Y, Kim HJ, et al. Current status and characteristics of hypertension treatment by primary physicians in Korea: data from Korean epidemiology study on hypertension (KEY study). Am J Hypertens 2008;21:884-889.
DOI
ScienceOn
|
| 11 |
UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in Type 2 diabetes : UKPDS 38. BMJ 1998;317:703-713.
DOI
ScienceOn
|
| 12 |
Jeffrey S. New JNC 7 hypertension guidelines released 2003. Available from: http://www.theheart.org/article/.
|
| 13 |
Lee TY, Reconsideration of hypertension awareness, treatment, and control. Korean Hypertension J 2009;15:1-6.
|
| 14 |
Taler SJ, Textor SC, Augustine JE. Resistant hypertension: comparing hemodynamic management to specialist care. Hypertension 2002;39:982-988.
DOI
ScienceOn
|
| 15 |
Hirsch S. A different approach to resistant hypertension. Clev Clin J Med 2007;74:449-456.
DOI
ScienceOn
|
| 16 |
Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. Lancet 1998;351:1755-1762.
DOI
ScienceOn
|
| 17 |
Winker MA, Murphy MB. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final result of the systolic hypertension in elderly program (SHEP). JAMA 1991;265:3255-3264.
DOI
ScienceOn
|
| 18 |
Park GS, Ra HJ, Joe HG, et al. Pattern of hypertensive management and usefulness of treatment guideline in primary care. J Korean Acad Fam Med 2006;27:789-797.
|
| 19 |
Ostchega Y, Yoon SS, Hughes J, Louis T. Hypertension awareness, treatment, and control - continued disparities in adults: United States, 2005-2006. NCHS Data Brief 2008:1-8.
|
| 20 |
질병관리본부. 2008년 국민건강통계-국민건강영양조사 제4기 2차년도 조사결과 보고서. 2009.
|
| 21 |
Mancia G, De Backer G, Dominiczak A, et al. 2007 guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the european society of hypertension (ESH) and the European society of cardiology (ESC). J Hypertens 2007;25:1105-1187.
DOI
ScienceOn
|
webmaster
